AI and machine-learning advances have made it possible to produce fake videos and photos that seem real, commonly known as “deepfakes.” Deepfake content is expl

The U.S. Food and Drug Administration (FDA) is showing its dedication to the advancement of digital health technology with two recent announcements:  a new Digi

Our new Life Sciences MoFo Perspectives podcast is available now. In this episode, several of our Life Sciences Group partners unpack the science, regulatory fr

The USPTO recently released the report “Public Views on Artificial Intelligence and Intellectual Property Policy”. The report is part of the USPTO’s effort to e

A White Paper on Artificial Intelligence (AI) from the European Commission provides insight on how governments might change product safety and liability rules t

The New ABC's: Artificial Intelligence, Blockchain and How Each Complements the Other BSA/AML compliance programs in the United States are often associated with

Artificial intelligence (AI) and blockchain technology are two novel innovations that offer the opportunity for us to move beyond our legacy systems and streaml

The European Patent Office has denied two patent applications on the grounds that an AI system cannot be listed as the inventor. For the first time, the Europe

On January 6, 2020, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) published an interim final rule amending the Export Administration R

The U.S. Department of Commerce (“Commerce”) has added 28 Chinese organizations to the Bureau of Industry and Security (BIS) Entity List, a move that effectivel